Fabio Fuligni
Fabio Fuligni
Quest Diagnostics
Verified email at
Cited by
Cited by
The tomato genome sequence provides insights into fleshy fruit evolution
xx Tomato Genome Consortium
Nature 485 (7400), 635, 2012
Diversity of bifidobacteria within the infant gut microbiota
F Turroni, C Peano, DA Pass, E Foroni, M Severgnini, MJ Claesson, ...
PloS one 7 (5), e36957, 2012
Comprehensive analysis of hypermutation in human cancer
BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ...
Cell 171 (5), 1042-1056. e10, 2017
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition
MR Sapienza, F Fuligni, C Agostinelli, C Tripodo, S Righi, MA Laginestra, ...
Leukemia 28 (8), 1606-1616, 2014
Distinct viral and mutational spectrum of endemic Burkitt lymphoma
F Abate, MR Ambrosio, L Mundo, MA Laginestra, F Fuligni, M Rossi, ...
PLoS pathogens 11 (10), e1005158, 2015
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors
ND Anderson, R de Borja, MD Young, F Fuligni, A Rosic, ND Roberts, ...
Science 361 (6405), eaam8419, 2018
Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study
PP Piccaluga, F Fuligni, A De Leo, C Bertuzzi, M Rossi, F Bacci, ...
J Clin Oncol 31 (24), 3019-3025, 2013
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma
S Sangaletti, C Tripodo, C Vitali, P Portararo, C Guarnotta, P Casalini, ...
Cancer discovery 4 (1), 110-129, 2014
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target
MR Sapienza, F Abate, F Melle, S Orecchioni, F Fuligni, M Etebari, ...
haematologica 104 (4), 729, 2019
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study
C Agostinelli, A Gallamini, L Stracqualursi, P Agati, C Tripodo, F Fuligni, ...
The Lancet Haematology 3 (10), e467-e479, 2016
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
E Derenzini, C Agostinelli, E Imbrogno, I Iacobucci, B Casadei, ...
Oncotarget 6 (9), 6553, 2015
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies
A Gazzola, C Mannu, M Rossi, MA Laginestra, MR Sapienza, F Fuligni, ...
Therapeutic advances in hematology 5 (2), 35-47, 2014
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T‐cell lymphoma
E Marchi, KM Zullo, JE Amengual, M Kalac, D Bongero, CM McIntosh, ...
British journal of haematology 171 (2), 215-226, 2015
SOCS2 controls proliferation and stemness of hematopoietic cells under stress conditions and its deregulation marks unfavorable acute leukemias
C Vitali, C Bassani, C Chiodoni, E Fellini, C Guarnotta, S Miotti, ...
Cancer research 75 (11), 2387-2399, 2015
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway
PP Piccaluga, M Rossi, C Agostinelli, F Ricci, A Gazzola, S Righi, ...
Leukemia 28 (8), 1687-1697, 2014
Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas
PP Piccaluga, M Navari, G De Falco, MR Ambrosio, S Lazzi, F Fuligni, ...
Oncotarget 7 (1), 224, 2016
Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma
G Franco, C Guarnotta, B Frossi, PP Piccaluga, E Boveri, A Gulino, ...
Blood, The Journal of the American Society of Hematology 123 (12), 1836-1849, 2014
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
MA Laginestra, L Cascione, G Motta, F Fuligni, C Agostinelli, M Rossi, ...
Modern Pathology 33 (2), 179-187, 2020
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
ND Anderson, Y Babichev, F Fuligni, F Comitani, M Layeghifard, ...
Nature communications 12 (1), 4496, 2021
Direct transcriptional consequences of somatic mutation in breast cancer
A Shlien, K Raine, F Fuligni, R Arnold, S Nik-Zainal, S Dronov, ...
Cell reports 16 (7), 2032-2046, 2016
The system can't perform the operation now. Try again later.
Articles 1–20